American Diabetes Association competitors

Knudsen previously servesd as the executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health, one of only 71 National Cancer Institute-Designated Cancer Centers recognized for its research and impact on cancer outcomes. She also holds leadership roles with some of the most important cancer entities in the nation. She is the president of the Association of American Cancer Institutes, where her platform has focused on diversity, equity and inclusion, and serves on the board of directors for the American Association of Cancer Research and the board of advisors for the National Cancer Institute. She is active in committees for the American Society for Clinical Oncology, in addition to serving on other academic and for-profit advisory boards. Knudsen holds a bachelor's degree in biology from the George Washington University; a Ph.D. in biological sciences from the University of California San Diego; and an MBA from Temple University Fox School of Business.

Cynthia Zagieboylo is a President & CEO at NATIONAL MULTIPLE SCLEROSIS SOCIETY and is based in United States. She has worked as Vice President, Chapter Programs at NATIONAL MULTIPLE SCLEROSIS SOCIETY and Chief Field Services Officer at NATIONAL MULTIPLE SCLEROSIS SOCIETY. Cynthia attended University of Connecticut between 1982 and 1984 and Springfield College between 1978 and 1982.

Michael Boyle, MD, is president and chief executive officer. Prior to his appointment as president and CEO, Dr. Boyle served as senior vice president, therapeutics development at the Cystic Fibrosis Foundation from 2015-2019. In that role, Dr. Boyle shaped the Foundation's clinical research strategy, overseeing the clinical development programs of new treatments for the CF Foundation, as well as the Foundation's Therapeutics Development Network of 92 academic research centers. Dr. Boyle is internationally known for his clinical research and for his work to improve care for adults with CF. He served as both an investigator in the clinical study of Kalydeco® and principal investigator of the pivotal trial that led to approval of the first combination treatment, Orkambi®. Dr. Boyle completed his medical training at Johns Hopkins University, including a fellowship in pulmonary and critical care medicine, before joining the medical faculty in 1999. Dr. Boyle founded the Johns Hopkins University Adult CF Program -- one of the largest in the United States -- in 1999 and served as director of that center for close to two decades. Today, he is an adjunct professor of medicine at Johns Hopkins, where he continues to see patients. In addition to his medical background, Dr. Boyle has completed training in nonprofit management at both Johns Hopkins and Harvard University.

Independent advisor to high-growth potential technology companies, supporting early stage entrepreneurs as they execute their vision and build for scale. Former large-company executive with large-scale M&A, Product Marketing, Business Development and Operational experience. Successful small business owner who successfully transitioned a traditional brick and mortar business to the internet world. Financially savvy, highly practical, no hubris. Easily scales between strategy and tactics. I build the bridge between the vision and the operating plan. Contributor to non-profit organizations with talent and treasure. Life-long mentor to many.